Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Conference Highlights
IDWeek
IDWeek 2018
IDWeek 2018
Unintended Consequences of Fluoroquinolone Stewardship: Impact on Overall Antimicrobial Use Data and Implications for Benchmarking
IDWeek 2018
A successful antibiotic stewardship intervention can reduce the usage of fluoroquinolones for patient safety and resistance concerns in community-acquired pneumonia.
Read More ›
Omadacycline In Vitro Activity Against a Molecularly Characterized Collection of Clinical Isolates with Known Tetracycline Resistance Mechanisms
IDWeek 2018
Investigators evaluated the in vitro activity of omadacycline, a novel aminomethylcycline antibiotic, against a collection of clinical isolates resistant to other available tetracyclines.
Read More ›
Geographic Distribution of Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae Across Veterans Health Administration Outpatient Settings
IDWeek 2018
When considering antibiotic-prescribing guidelines in the community setting, is “one size fits all” applicable in the face of emerging extended-spectrum cephalosporin-resistant
Enterobacteriaceae
?
Read More ›
Phase 3 Trials Show Omadacycline’s Efficacy Against Molecularly Characterized Gram-Positive and Gram-Negative Pathogens Causing Infections
IDWeek 2018
The efficacy of omadacycline was demonstrated in Gram-positive and Gram-negative clinical isolates from 3 completed phase 3 trials involving tetracycline nonsusceptible pathogens.
Read More ›
Escherichia Coli Community-Acquired Pneumonia
IDWeek 2018
Researchers compared epidemiologic and healthcare resource utilization data on
Escherichia coli
community-acquired bacterial pneumonia with that of pneumococcal community-acquired bacterial pneumonia.
Read More ›
Improvement in Quality of Life for Adults with Acute Bacterial Skin and Skin Structure Infections After Omadacycline or Linezolid Treatment
IDWeek 2018
Omadacycline provides significant improvement in the physical component of quality of life for adult subjects with an acute bacterial skin and skin structure infection known or suspected to be due to a Gram-positive pathogen.
Read More ›
Socioeconomic Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy
IDWeek 2018
Socioeconomic factors play a significant role in hospital readmission following outpatient parenteral antimicrobial therapy.
Read More ›
Hospital Admission Patterns in Patients with Community-Acquired Bacterial Pneumonia Who Received Ceftriaxone and a Macrolide
IDWeek 2018
Can costs associated with community-acquired bacterial pneumonia be reduced by implementing the site-of-care indicators regarding severity of illness recommended in the IDSA/ATS CAP guidelines?
Read More ›
Pooled Analysis of IGNITE1 and IGNITE4 Shows Activity of Eravacycline in Complicated Intra-Abdominal Infections
IDWeek 2018
Eravacycline 1 mg/kg every 12 hours was demonstrated to be noninferior to ertapenem 1 g intravenously every 24 hours or meropenem in patients with complicated intra-abdominal infections.
Read More ›
Expediting Discharge in Acute Bacterial Skin and Skin Structure Infections: Comparing Vancomycin with Oritavancin
IDWeek 2018
The use of oritavancin is a strategy to address the high economic burden secondary to prolonged hospitalization and high rates of recurrent infections associated with acute bacterial skin and skin structure infections.
Read More ›
Page 1 of 3
1
2
3
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us